Abstract
The term “metronomic” was recently introduced to describe continuous low-dose administration of chemotherapeutics following the discovery that this causes minimal side effects (Hanahan et al. 2000, J Clin Invest, 105(8), 1045–1047; Bisland et al. 2004, Photochem Photobiol, 80, 22–30). Metronomic dosing in PDT is proposed by analogy and the rationale is as a means to improve the tumor-specific response through cell death by apoptosis. We investigated the molecular mechanisms associated with apoptosis following ALA-PDT treatment in two brain glioma cell lines, namely U87 (human) and CNS-1 (rat) cells. We used the high energy of light at a short time (acute PDT) and the low energy of light at a long time of exposure (metronomic PDT) to treat both cell lines. To identify potential cell death pathways associated with metronomic PDT, microarray analysis of gene expression was conducted on RNA from glioblastoma cells with metronomic ALA-PDT. The apoptosis mechanism for metronomic ALA-PDT occurred via the inhibition of LTβR and the transcription factor NF-κB. This inhibition was ALA concentration dependent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oltvai, Z. N. and Korsmeyer, S. J. (1994) Checkpoints of dueling dimers foil death wishes. Cell, 79, 189–192.
Reed, J. C. (1995) Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemo resistance. Curr Opin Oncol, 7, 541–546.
Korsmeyer, S. J. (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res, 59, 1693s–1700s.
Srivastava, M., Ahmad, N., Gupta, S., and Mukhtar, H. (2001) Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem, 276, 15481–15488.
Shen, X. Y., Zacal, N., Singh, G., and Rainbow, A. J. (2005) Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol, 81, 306–313.
Chiu, S. M., Xue, L. Y., Azizuddin, K., and Oleinick, N. L. (2005) Photodynamic therapy-induced death of HCT 116 cells: apoptosis with or without Bax expression. Apoptosis, 10, 1357–1368.
Barnhart, B. C., Alappat, E. C., and Peter, M. E. (2003) The CD95 type I/type II model. Semin Immunol, 15, 185–193.
Micheau, O. and Tschopp, J. (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell, 114, 181–190.
Varfolomeev, E. E. and Ashkenazi, A. (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell, 116, 491–497.
Wang, S. and El Deiry, W. S. (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene, 22, 8628–8633.
Ashkenazi, A. (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer, 2, 420–430.
Xue, L. Y., Chiu, S. M., and Oleinick, N. L. (2001) Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp Cell Res, 263, 145–155.
Eleouet, S., Rousset, N., Carre, J., Bourre, L., Vonarx, V., Lajat, L., Beijersbergen, G. M., Henegouwen, V., and Patrice, T. (2000) In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol, 71, 447–454.
Stummer, W., Stocker, S., Novotny, A., Heimann, A., Sauer, O., Kempski, O., Plesnila, N., Wietzorrek, J., and Reulen, H. J. (1998) In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B, 45, 160–169.
Wilson, C. and Browning, J. (2002) Death of HT-29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ, 9, 1321–1333.
Wajant, H., Gerspach, J., and Pfizenmaier, K. (2005) Tumor therapeutics by design: targeting and activation of death receptors. Cytokine Growth Factor Rev, 16, 55–76.
Tamada, K. and Chen, L. (2006) Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules. Cancer Immunol Immunother, 55, 355–362.
Acknowledgments
This work was supported by PO1 CA043892-16.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Singh, G., Alqawi, O., Espiritu, M. (2010). Metronomic PDT and Cell Death Pathways. In: Gomer, C. (eds) Photodynamic Therapy. Methods in Molecular Biology, vol 635. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-697-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-697-9_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-696-2
Online ISBN: 978-1-60761-697-9
eBook Packages: Springer Protocols